Fluor bags Baxter’s biotechnology facility contract in Georgia, US

IRVING, US: Fluor Corporation is currently performing early construction management services for Baxter International’s new biotechnology facility near Covington, Georgia, about 45 miles southeast of Atlanta. Mass excavation and earth works are underway at the project site. Fluor previously booked its share of the project value in the third quarter of 2012.

Commercial production at Baxter’s new facility is scheduled to begin in 2018. The Covington site will have the flexibility and necessary infrastructure to expand further to support additional global market needs. Fluor’s Greenville, US office will provide support to the onsite construction management team. The construction labour workforce is expected to total about 2,200 at construction peak.

“Fluor is proud that our project and construction management services will help Baxter make this facility a reality to create therapies to treat a number of chronic and acute conditions, including immune deficiencies and critical care patients around the world,” said Steve Dobbs, President, Industrial & Infrastructure Business Group, Fluor.

© WOC News